Prince HM - Search Results

1

Immunotherapy of multiple myeloma: the start of a long and tortuous journey.

Harrison SJ, Cook G, Nibbs RJ, Prince HM. Harrison SJ, et al. Among authors: prince hm. Expert Rev Anticancer Ther. 2006 Dec;6(12):1769-85. doi: 10.1586/14737140.6.12.1769. Expert Rev Anticancer Ther. 2006. PMID: 17181491 Review.

2

The adverse prognostic impact of advanced age in multiple myeloma.

Mileshkin L, Prince HM. Mileshkin L, et al. Among authors: prince hm. Leuk Lymphoma. 2005 Jul;46(7):951-66. doi: 10.1080/10428190500085024. Leuk Lymphoma. 2005. PMID: 16019546 Review.

3

Current status of new drugs for the treatment of patients with multiple myeloma.

Kenealy M, Prince HM. Kenealy M, et al. Among authors: prince hm. Intern Med J. 2006 Dec;36(12):781-9. doi: 10.1111/j.1445-5994.2006.01218.x. Intern Med J. 2006. PMID: 17096741 Review.

4

Myeloma, thalidomide and thrombosis.

Hönemann D, Prince HM. Hönemann D, et al. Among authors: prince hm. Leuk Lymphoma. 2006 Nov;47(11):2273-5. doi: 10.1080/10428190600908562. Leuk Lymphoma. 2006. PMID: 17107896 No abstract available.

5

The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study.

Feyler S, Prince HM, Pearce R, Towlson K, Nivison-Smith I, Schey S, Gibson J, Patton N, Bradstock K, Marks DI, Cook G. Feyler S, et al. Among authors: prince hm. Bone Marrow Transplant. 2007 Sep;40(5):443-50. doi: 10.1038/sj.bmt.1705752. Epub 2007 Jun 25. Bone Marrow Transplant. 2007. PMID: 17589529

6

Treatment strategies in elderly patients with multiple myeloma: current status.

Quach H, Prince HM, Mileshkin L. Quach H, et al. Among authors: prince hm. Drugs Aging. 2007;24(10):829-50. doi: 10.2165/00002512-200724100-00004. Drugs Aging. 2007. PMID: 17896832 Review.

7

Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.

Bishton M, Kenealy M, Johnstone R, Rasheed W, Prince HM. Bishton M, et al. Among authors: prince hm. Expert Rev Anticancer Ther. 2007 Oct;7(10):1439-49. doi: 10.1586/14737140.7.10.1439. Expert Rev Anticancer Ther. 2007. PMID: 17944568 Review.

8

The potential of histone deacetylase inhibitors for the treatment of multiple myeloma.

Prince HM, Bishton M, Harrison S. Prince HM, et al. Leuk Lymphoma. 2008 Mar;49(3):385-7. doi: 10.1080/10428190801950058. Leuk Lymphoma. 2008. PMID: 18297514

9

Histone deacetylase inhibitors in lymphoma and solid malignancies.

Rasheed W, Bishton M, Johnstone RW, Prince HM. Rasheed W, et al. Among authors: prince hm. Expert Rev Anticancer Ther. 2008 Mar;8(3):413-32. doi: 10.1586/14737140.8.3.413. Expert Rev Anticancer Ther. 2008. PMID: 18366289 Review.

10

The development of novel immunotherapeutic approaches in multiple myeloma.

Peinert S, Prince HM, Harrison S. Peinert S, et al. Among authors: prince hm. Leuk Lymphoma. 2008 Apr;49(4):652-4. doi: 10.1080/10428190802007742. Leuk Lymphoma. 2008. PMID: 18398729 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

447 results

Search Page

Filters